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Abstract
The presence of unusual natural killer cells in human endometrium has
been recognized for 30 years, but despite considerable research effort, the 
 role of uterine natural killer (uNK) cells in both normal andin vivo
pathological pregnancy remains uncertain. uNK cells may differentiate from
precursors present in endometrium, but migration from peripheral blood in
response to chemokine stimuli with   modification to a uNK cellin situ
phenotype is also possible. uNK cells produce a wide range of secretory
products with diverse effects on trophoblast and spiral arteries which may
play an important role in implantation and early placentation. Interactions
with other decidual cell populations are also becoming clear. Recent
evidence has demonstrated subpopulations of uNK cells and the presence
of other innate lymphoid cell populations in decidua which may refine future
approaches to investigation of the role of uNK cells in human pregnancy.
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Introduction
Granulated cells were recognized in endometrial stroma almost 
a century ago, but despite light and electron microscopic evi-
dence for a lymphocyte origin in humans1, mouse2,3, and rat4, 
they were regarded as stromal cells until identified as unusual 
natural killer (NK) cells using monoclonal antibodies5–7. The 
term uterine NK (uNK) cell has been commonly adopted, 
although “decidual NK cell” and “endometrial NK cell” 
are also used to reflect their presence only in endometrium. 
uNK cells, characterized as CD45+CD56brightCD16+CD9+, 
increase in number in luteal phase endometrium and early 
pregnancy decidua7–10. A substantial number remain in later 
pregnancy11,12, although fewer have cytoplasmic granules, 
explaining why early studies relying on identifying cyto-
plasmic granules reported their virtual absence at full term13. 
This distribution suggests a role in pregnancy and this has been 
the focus of studies over the last 30 years.
Despite suggestions of a detrimental role of NK cells in early 
pregnancy failure, uNK cells are considered to be a positive 
force for healthy pregnancy, although their precise role remains 
uncertain. The recent identification of molecularly distinct 
uNK cell subgroups14 and other innate lymphoid cells (ILCs) in 
human decidua15–17 suggests that a re-appraisal may be timely. 
The aim of this review is to provide a brief overview of views 
on the origin and function of uNK cells that have developed 
over the last 30 years and consider future directions.
Origin of uterine natural killer cells
There is no consensus regarding the origin of uNK cells; their 
gene expression patterns differ from those of peripheral blood 
NK (pbNK) cells18, but whether they differentiate locally or are 
recruited to endometrium (or both) is uncertain. Hematopoietic 
precursor cells (HPCs) have been reported in non-pregnant 
endometrium19 and early pregnancy decidua20–22 at a frequency 
of 0.1% to 4%. HPCs purified from decidua and cultured in 
decidual stromal cell (DSC)-conditioned medium or various 
cytokine combinations produced CD56brightCD16−CD9+ 
uNK-like cells20–22. Additional evidence for local differen-
tiation comes from detection of increased CD56+ uNK cells in 
human proliferative endometrium transplanted into non-obese 
diabetic/severe combined immunodeficiency/γCnull immunode-
ficient mice subjected to menstrual cycle–mimicking hormone 
treatment23. In contrast, Male et al.24 did not detect HPCs 
in non-pregnant endometrium and suggested the possibility 
of local differentiation from stage 3 immature NK cells, 
although the cells detected in these studies express markers that 
are characteristic oftype 3 ILCs and produce interleukin-22 
(IL-22)17. Human endometrium produces several factors impli-
cated in NK cell differentiation, including IL-1525, IL-7, Flt3L26, 
SCF (KL)27–29, and transforming growth factor beta 1 (TGFβ1)30, 
many of which are increased in the luteal phase and early 
pregnancy.
Rather than differentiation from HPCs, it is possible that locally 
secreted chemokines/cytokines could attract pbNK cells to 
endometrium and also mediate further local differentiation. 
Purified CD16+CD9− pbNK cells converted into CD16−CD9+ 
uNK-like cells after culture with DSC-conditioned medium 
or TGFβ120,31, and a uNK cell-type phenotype (CD56brightC
D16−CD9+KIR+, VEGF-A producing, low cytotoxicity) was 
induced by exposure of pbNK cells to hypoxia, TGFβ1, and 
demethylating agents31. DSCs produce chemoattractants impli-
cated in recruitment of pbNK cells to endometrium, including 
C-X-C motif chemokine 10 (CXCL10), CXCL12, CX3CL1, 
and chemerin32,33, and compared with non-pregnant and male 
cells, pbNK cells from pregnant women have increased abil-
ity to migrate through DSCs26. Furthermore, pbNK cells acquire 
a uNK cell-type chemokine receptor pattern after co-culture 
with DSCs. NK cell populations could also be recruited into 
endometrium in pregnancy in response to trophoblast34.
uNK cells consistently localize to areas of stromal decidualiza-
tion, including progesterone-treated endometrium, intrauterine 
decidua in ectopic pregnancy, and extrauterine decidua in 
normal pregnancy. This indicates a role for DSCs in uNK cell 
differentiation or recruitment (or both) and clearly demonstrates 
that they are not (all) dependent on trophoblast. It seems likely 
that both recruitment from blood and local differentiation play 
a role but perhaps with different contributions in non-pregnant 
and pregnant endometrium. A developing population is sug-
gested by phenotypic differences with increasing gestation, 
and there is reduced expression of HLA-C–specific killer 
immunoglobulin-like receptors (KIRs) from 6 to 12 weeks35, 
increased NKG2D expression from 8 to 12 weeks36, increased 
expression of NKp80 and NKG2D, and a population with 
reduced CD56 brightness in second (13 to 20 weeks) compared 
with first (6 to 12 weeks) trimester11,37. Functional changes may 
also reflect an evolving population. Altered cytokine/growth 
factor expression and differing effects on trophoblast invasion 
have been reported in CD56+ uNK cells from 8 to 10 compared 
with 12 to 14 weeks of gestational age38–40, and a reduced pro-
portion of cells expressing granzyme and perforin13,37, reduced 
CD56+ cells in proximity to extravillous trophoblast (EVT), 
and altered interactions with HTR-8/SVneo trophoblast-like 
cells have been reported in the second compared with the first 
trimester of pregnancy37. These phenotypic and functional 
variations may reflect further local differentiation of immature 
NK cells or recruitment and further differentiation of additional 
populations from peripheral blood. CD56+ cells also prolifer-
ate in endometrium, and the highest expression of the prolif-
eration marker Ki67 (>40%) is in the mid/late luteal phase41 and 
this could account for phenotypic differences as the menstrual 
cycle and pregnancy progress. The biological significance of 
the phenotypic and functional changes related to gestational age 
is not known. In addition, whether any altered decidual NK cell 
populations in pathological pregnancy represent alteration of 
a resident uNK cell population or recruitment of an additional 
population has not been established.
Interaction with trophoblast
uNK cells express a range of receptors, including KIRs and 
leukocyte immunoglobulin-like receptors (LILRs) that can 
recognize HLA-E, HLA-G, and HLA-C, which are expressed by 
EVT42–45. uNK cell expression of these receptors differs from 
that of pbNK cells and is biased toward HLA-E and HLA-C1 
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recognition35. It was suggested that the bias toward HLA-C rec-
ognition resulted from pregnancy46, but studies using uNK cells 
from menstrual blood indicate that this receptor repertoire is estab-
lished in non-pregnant endometrium and does not differ between 
consecutive menstrual cycles47,48. Expression of these specific 
receptors by uNK cells suggests that they interact with EVT, 
and specific KIR/HLA-C combinations have been associ-
ated with pregnancy complications, including pre-eclampsia, 
fetal growth restriction, and recurrent miscarriage49–52. How-
ever, an epidemiological study of Japanese couples did not 
support this proposal, noting similar rates of pre-eclampsia in 
couples comprising Japanese women and Caucasian men and 
couples comprising Japanese men and women53. Furthermore, 
no association of HLA-C/KIR genotype with pre-eclampsia 
was noted in a recent Danish study, although this was confined 
to severe pre-eclampsia54.
There were early suggestions that uNK cells may limit EVT 
invasion by cytotoxicity, and some studies have suggested 
that uNK cells are capable of cytotoxic activity. Co-culture of 
IL-2–activated CD56bright decidual NK cells with an EVT-like 
cell line HTR-8/SV40neo led to granulolysin accumulation 
in the EVT cells, and transfection of granulolysin into 
HTR-8/SC40neo cells induced their apoptosis55. Furthermore, a 
more recent study detected cytotoxic activity by IL-2–stimulated 
CD56+ cells (>90% purity) from early pregnancy decidua 
against both cytotrophoblast and the NK target K562, an activity 
that was inhibited by decidual macrophages56. Nevertheless, 
in most studies, uNK cells have been poorly cytotoxic to both 
classic NK cell targets and trophoblast57, and the consensus 
is that uNK cells are not cytotoxic in healthy pregnancy. uNK 
cells can acquire cytotoxic ability when decidua is infected by 
pathogens such as cytomegalovirus and toxoplasma, suggesting a 
possible role in protection against infection58.
There are many reports of cytokine, chemokine, and growth 
factor production by uNK cells, mainly at a gestational age 
of 8 to 14 weeks, when trophoblast invasion and spiral artery 
remodeling are maximal; a summary is given in Table 1 but 
the list is not exhaustive. Several different approaches have 
been used for tissue disaggregation, uNK cell purification, 
and mechanisms and durations of cell activation; this may 
explain the variation between different studies.
Given the phenotypic changes, it is not surprising that the uNK 
cell secretome varies with gestational age. uNK cell produc-
tion of IL-1β, IL-6, CXCL8, granulocyte-macrophage colony-
stimulating factor (GM-CSF), and interferon-gamma (IFNγ) 
was increased at 12 to 14 weeks compared with 8 to 10 weeks 
of gestation39, whereas angiopoetin 2 (Ang2) and vascular 
endothelial growth factor-C (VEGF-C) secretion were higher 
at the earlier gestational age38. Increased cytokine levels at 12 
to 14 weeks may tie in with reports that interactions between 
pbNK cells and soluble HLA-G induce a pro-inflammatory/
pro-angiogenic senescence-associated secretory phenotype 
with increased secretion of, among others, IL-1β, IL-6, and 
CXCL859–61, although this has not been demonstrated for 
uNK cells. uNK cell secretory products are also altered by 
trophoblast; uNK cell secretion of Ang1, VEGF-C, IL-6, 
CXCL8, and TGFβ1 were reduced by co-culture with EVT 
and cytotrophoblast40. In contrast, increased IFNγ mRNA was 
reported after incubation of uNK cells with cytotrophoblast62. 
Interaction of HLA-C (expressed by EVT) with the activat-
ing receptors KIR2DS1 and KIR2DS4 expressed by uNK 
cells stimulates their production of cytokines, including GM-
CSF, which can stimulate trophoblast invasion in vitro63,64. 
Furthermore, a recent study demonstrated that, when co-cultured 
with EVT, a subset of uNK cells (CD49a+Eomes+) secrete 
growth-promoting factors, including pleiotrophin and osteoglycin; 
this effect is stimulated by HLA-G/ILT2 crosstalk65.
Among other chemokines and growth factors, uNK cells 
simulate trophoblast invasion by production of CXCL8 and 
CXCL1066, although decidual CD3+ T cells, which produce 
higher levels of CXCL8, did not stimulate EVT invasion67. Other 
cytokines produced by uNK cells, such as tumor necrosis fac-
tor alpha (TNFα) and IFNγ, inhibit invasion of EVT cells by 
various mechanisms, including trophoblast apoptosis, inhibi-
tion of proliferation, and reduced matrix metalloprotease (MMP) 
production68,69. The effect of uNK cells on EVT invasion may 
also depend on gestational age; in keeping with increased pro-
duction of cytokines such as CXCL8, uNK cell supernatants 
at 12 to 14 weeks of gestation stimulated trophoblast invasion, 
whereas those at 8 to 10 weeks had no effect70. In contrast, oth-
ers have reported reduced trophoblast migration from villous 
explants co-cultured with decidual CD56+ cells, and the effect was 
mediated by IFNγ62,71.
uNK cells have a complex array of secretory products which 
may alter with different approaches to purification and acti-
vation. Despite the many and varied reports, the in vivo 
relevance of these studies remains unclear. Examination of any 
one cytokine is unlikely to reflect its importance in vivo, which 
may vary with gestational age; for example, a role in spiral artery 
remodeling may shift in later gestation to promoting trophob-
last invasion. In regard to the role of uNK cells in the regula-
tion of trophoblast invasion, it is important to remember that 
the cells are confined to decidua/endometrium, whereas even 
in the first trimester of normal pregnancy, interstitial trophoblast 
invades into inner myometrium72. Trophoblast also invades into 
myometrium in placenta accreta spectrum disorders, in which 
decidua (and uNK cells) are absent73. Therefore, other fac-
tors, including the inherent invasive capacity of EVT following 
epithelial–mesenchymal transition74,75 and other maternal 
cell populations, must play a role.
Interaction with spiral arteries
Remodeling of spiral arteries in decidua basalis and underly-
ing superficial myometrium is essential for healthy pregnancy 
and it is now accepted that, in addition to trophoblast, maternal 
uterine cells play a role76,77, although the presence of trophob-
last may be required for the uNK cell effect78. Morphological 
changes in spiral arteries and arterioles in luteal phase 
endometrium and intrauterine decidua in ectopic pregnancy also 
suggest a trophoblast-independent effect76.
uNK cells from decidua of 8 to 10 weeks, but not 12 to 14 weeks, 
of gestation can induce separation of vascular smooth muscle 
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cells and loss of extracellular matrix via secretion of Ang1, 
Ang2, VEGF-C, and IFNγ87. uNK cells (and macrophages) 
also produce MMPs that can break down collagen in an in vitro 
spiral artery model88. uNK cell supernatants also mediate vascu-
lar smooth muscle cell dedifferentiation and this effect is seen at 
12 to 14 weeks but not 8 to 10 weeks of gestation89. Other chem-
okines and growth factors have been implicated in the uNK cell 
effect on spiral arteries. For example, Choudhury et al.90 sug-
gested that IL-6 and CXCL8 secreted by EVT activate secretion 
of C-C motif chemokine 14 (CCL14) and CXCL6 by endothe-
lial cells which then recruit uNK cells and macrophages to 
spiral arteries. Both IL-6 and CXCL8 also induce dedif-
ferentiation of vascular smooth muscle cells in a chorionic 
plate artery model91.
Altered decidual leucocytes have been reported in pre-eclamp-
sia, although results have varied92–94; there have been reports of 
reduced95–98, unchanged99, and increased100,101 uNK cells com-
pared with controls. Uterine artery Doppler studies in early preg-
nancy can predict women at increased risk of developing pre-
eclampsia in later pregnancy102; compared with post-delivery 
samples, these high-risk samples allow investigation when 
the pathogenetic lesion develops, before compensatory 
measures are in place, and this approach has been used to 
investigate uNK cell function in pregnancies at high risk of 
developing pre-eclampsia. uNK cells from 9- to 14-week ges-
tational age pregnancies with abnormal Doppler wave forms 
showed reduced expression of KIR2DL/S1,3,5 and LILRB185, 
reduced stimulation of trophoblast outgrowth from villous 
explants83, reduced in vitro induction of apoptosis in vascular 
smooth muscle cells and endothelial cells82, increased ang-
iogenic growth factor secretion84, and reduced ability to destabi-
lize endothelial structures103. These results all suggest that uNK 
cells from pregnancies at increased risk of pre-eclampsia display 
altered effects on trophoblast invasion and spiral arteries 
and emphasize the likely importance of uNK cells in early preg-
nancy. Nevertheless, in common with trophoblast invasion, 
spiral artery remodeling extends into inner myometrium. 
CD14+ macrophages and CD3+ T cells are present in the wall 
and adventitia of spiral arteries in both decidua and superficial 
myometrium104, suggesting that these cells also have a 
role, either alone or in collaboration with uNK cells.
Interactions with other cells
uNK cells may also interact with other cell types in non-preg-
nant and pregnant endometrium. uNK cells interact with CD14+ 
cells in decidua to produce IDO (indoleamine-2,3-dioxyge-
nase), which induces regulatory T cells105. This interaction 
appears to be mediated by IFNγ and TGFβ and is not seen with 
pbNK cells or CD14+ cells. uNK cells also form conjugates with 
immature dendritic cells in first-trimester decidua106–108 which 
can induce uNK cell proliferation and cytotoxicity109. It has 
also been suggested that uNK cells induce apoptosis of CD209 
(DC-SIGN)+ dendritic cells in decidua108. Evidence from 
mouse pregnancy suggests that IL-10 secreted by uNK cells 
regulates dendritic cell phenotype and function, and IL-10 
deficiency and dendritic cell expansion are associated with early 
pregnancy failure110.
In addition to affecting their recruitment or differentiation 
(or both), DSCs may affect uNK cell function; cultured first- 
trimester DSCs inhibited proliferation, cytotoxicity, IFNγ 
production, and upregulation of activation receptor expression 
by pbNK cells111. In non-pregnant endometrium, uNK cells may 
clear senescent decidual cells at the end of the menstrual 
cycle, playing a crucial role in endometrial homeostasis112.
Summary
Knowledge has increased dramatically since their recognition 
as unusual NK cells, but despite considerable research effort, 
the in vivo role of uNK cells remains unclear. Recent advances 
suggest that a re-appraisal may be timely. Whether uNK cell 
phenotype and function differ between non-pregnant and preg-
nant endometrium, between decidua basalis and parietalis, or 
at different sites within decidua (such as those related to spiral 
arteries) and at different gestational ages remains largely 
unknown. Pre-eclampsia, fetal growth restriction, and recur-
rent pregnancy failure have been associated with altered uNK 
cell numbers and function and specific KIR/HLA-C combina-
tions but the significance of these observations is not fully estab-
lished. uNK cells produce a wide range of chemokines, cytokines, 
growth factors, and MMPs, and many have been shown to 
have specific effects on trophoblast or spiral arteries, but 
in vivo translation is difficult. Gestational age differences in 
phenotype and function suggest that including samples across 
a range of gestational weeks in the first trimester may result in 
skewing of data.
The starting point for most studies of uNK cell function is 
decidua retrieved from pregnancy terminations or miscar-
riages. uNK cells within these samples have been exposed 
directly to EVT or to soluble HLA-G with possible functional 
effects. Investigations of uNK cells purified from non-pregnant 
endometrium are relatively infrequent, although several studies 
have reported increased uNK cells in luteal phase endometrium in 
recurrent early pregnancy failure113–116. A recent study of uNK 
cells from timed luteal phase endometrium reported increased 
expression of angiogenin, VEGF-A, and basic fibroblast growth 
factor (bFGF) in women with recurrent miscarriage compared 
with fertile controls86. Recent studies indicate that menstrual 
blood may act as a surrogate for endometrial NK cells47,48,117 
and this approach may increase the scope for future studies.
A single-cell RNA-sequencing (scRNA-seq) study of first- 
trimester decidua recently defined three distinct uNK cell 
populations15. The first (termed dNK1) contained more cytoplas-
mic granules, higher cytoplasmic granule proteins, and higher 
expression of KIR genes able to bind to HLA-C; LILRB1, which 
has high affinity for HLA-G, was expressed only by the dNK1 
subset, suggesting that this subset interacts particularly with 
EVT. The second population (dNK2) also expressed activat-
ing NKG2C and NKG2E and inhibitory NKG2A receptors for 
HLA-E molecules, whereas the third population (dNK3) did 
not express these receptors but did express CCL5, suggesting 
a role in the regulation of EVT invasion via C-C motif chem-
okine receptor 1 (CCR1). This report demonstrates subpopula-
tions of uNK cells which are likely to have diverse functions. 
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Similar studies of pathological pregnancy and non-pregnant 
endometrium, including endometrial NK cell populations in 
women with recurrent early pregnancy failure, may clarify the 
roles of specific uNK cell subsets in pathological pregnancy. The 
suggestion that there are subsets of NK cells in human decidua 
is supported by a report of production of growth-promoting fac-
tors by CD49a+Eomes+ uNK cells via interactions with HLA-G65, 
as well as the demonstration of a subpopulation of “pregnancy-
trained” uNK cells in repeated compared with first pregnancies, 
characterized by high expression of the receptors NKG2C 
and LILRB1 and increased IFNγ and VEGF-A secretion118.
Besides uNK cells, other innate lymphoid cells have been iden-
tified in human decidua15–17, including CD56+CD94− non-cyto-
toxic type 1 ILCs (ILC1s), CD56−CD117+CD127+ lymphoid 
tissue inducer (LTi)-like cells, and CD56+CD94−CD117+CD12
7+NKp44+ type 3 ILCs (ILC3s). These ILCs may contribute to 
the cytokine production reported by decidual CD56+ cells. For 
example, ILC1s may contribute to IFNγ production, while ILC3s 
produce IL-22 and CXCL8, which may regulate neutrophil 
recruitment119. The distribution and function of the different 
ILC populations are still unknown, although it has been 
suggested that ILC3 cytokine production may be regulated by 
programmed cell death (PD-1) expressed by ILC3s and its ligand 
PD-L1 expressed by EVT120.
It is now clear that “uNK cells” are not a single population and 
the relative importance of these subpopulations may change 
as gestation progresses. ILCs in decidua may contribute to the 
reported cytokine production by CD56+ uNK cells and this may 
differ according to different purification and activation protocols. 
Abnormal function in pathological pregnancy could affect 
specific uNK cell subpopulations or ILCs. Rather than refer-
ring to “uNK cells”, perhaps we should dissect populations 
more precisely and consider the functional contribution of ILCs. 
Technical advances may allow localization of different sub-
populations, and investigation of pathological pregnancies 
may provide valuable clues to function. The advent of scRNA-
seq technology provides an exciting way forward to unravel the 
role of uNK cells in normal and pathological pregnancy, making 
it possible to target specific cell populations for more accurate 
diagnosis and potential intervention.
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